Intravenous lidocaine as adjuvant to general anesthesia in renal surgery

Figures & data

Table 1. Patients characteristics.

	Group C (n = 30)	Group L (n = 30)	P
Age (years)	59 ± 12	53 ± 14	0.11
Gender male/female (n)	19/11	20/10	0.78
ASA 1/2 (n)	19/11	22/8	0.40
BMI kg.m^−2	25.2 ± 4.3	26.7 ± 4.8	0.18
Type of surgery:
Pyelotomy (n)/Nephrectomy (n)	19/11	21/9	0.58
Duration of surgery (min)	78.8 ± 25.1	76.9 ± 28.0	0.78
Duration of anesthesia (min)	97.5 ± 25.6	95.3 ± 28.6	0.75

Data are reported as mean (± SD) or numbers of patients; C: Group control; L: Group lidocaine; ASA: American Society of Anesthesiologists; BMI: body mass index

Figure 1. Intra operative BIS.

Figure 2. Intra operative mean blood pressure at all time point.

Figure 3. Intra operative heart rate at all time point.

* p < 10^–3

Figure 4. Et-Isoflurane concentrations at all time point.

* p < 10^–3

Figure 5. MAC of Isoflurane at all time point.

* p < 10^–3